NCT07549724 Clinical and Instrumental Assessment Tools for Neurogenic Dysphagia: Translation and Validation
| NCT ID | NCT07549724 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Camillo, Venezia, Italy |
| Condition | Dysphagia |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-09 |
| Primary Completion | 2028-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-09 with a primary completion date of 2028-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to translate and validate Italian versions of several clinical assessment tools for patients with neurogenic dysphagia. The instruments include: The New Zealand Secretion Severity Scale, which evaluates secretion management; The Reflex Cough Test from the I\&I cranial nerves assessment; The VASES scale used during fiberoptic endoscopic evaluation of swallowing; The Drooling Severity Scale, which measures saliva control. The study will include approximately 100 patients with neurogenic dysphagia. The goal is to provide reliable, standardized tools in Italian to support clinicians in assessing swallowing and oral-motor function in patients with neurological disorders.
Eligibility Criteria
IInclusion Criteria: Adult patients (≥18 years) diagnosed with neurogenic dysphagia due to any neurological condition (e.g., stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury) Able to understand and comply with study procedures Provide written informed consent (or legal representative consent if necessary) Stable medical and neurological condition at the time of assessment Exclusion Criteria: Active respiratory infection or acute illness affecting swallowing at the time of assessment History of head and neck surgery or anatomical abnormalities preventing standardized assessment of swallowing or reflex cough Severe uncontrolled comorbidities (cardiac, pulmonary, or systemic) that make study participation unsafe
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07549724 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Dysphagia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07549724 currently recruiting?
Yes, NCT07549724 is actively recruiting participants. Contact the research team at sara.nordio@hsancamillo.it for enrollment information.
Where is the NCT07549724 trial being conducted?
This trial is being conducted at Venezia, Italy.
Who is sponsoring the NCT07549724 clinical trial?
NCT07549724 is sponsored by IRCCS San Camillo, Venezia, Italy. The trial plans to enroll 100 participants.